Tag Archives: Dr Reddy’s Laboratories

27 of 45 drug-manufacturing units that received warning letters from US FDA were based in India

Mumbai: A report by Nomura Research reveals that 27 of the 45 drug manufacturing units that received warning letters from the US Food and Drug Administration (FDA) between 2011 and May 2016, over poor data integrity, were India-based plants belonging to, among others, Wockhardt, Sun Pharmaceutical, Dr Reddy’s Laboratories, Cadila Healthcare, Sandoz, IPCA Laboratories and Mylan Laboratories.

Posted in NEWS, Pharmaceuticals | Tagged , , , , , , , , , | Leave a comment

Dr Reddy’s Q3 profit rises by 230.7 percent

Hyderabad: Leading pharmaceutical company Dr Reddy’s Laboratories Ltd said it posted a standalone net profit of Rs 236.8 crore for the quarter ending December 31, 2015.

Posted in NEWS, Pharmaceuticals | Tagged | Leave a comment

How India tackles adverse drug reactions — by ignoring data

With 10 percent of 3.63 trillion medicines popped worldwide in 2015, India is the world’s third-largest medicine market. It stands to scientific reason that these drugs will have side effects.

Posted in FEATURES | Tagged , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Dr Reddy’s Sernivo spray gets US FDA nod

Chennai: Indian drug major Dr Reddy’s Laboratories Ltd on Monday said its wholly owned US subsidiary Promius Pharma has got the US FDA approval for a spray to treat plaque psoriasis.

Posted in NEWS, Pharmaceuticals | Tagged , , , , , , , | Leave a comment

Dr Reddy’s signs MoU for skill development in life sciences

Hyderabad: Pharma major Dr Reddy’s on Monday said it has signed a memorandum of understanding (MoU) with the Life Sciences Sector Skill Development Council (LSSSDC) and Vishnu Institute of Pharmaceutical Education and Research (VIPER) to strengthen the skilled labour pool in the life science industry.

Posted in NEWS | Tagged , , , , , , , | Leave a comment

‘Withdrawal of tax exemption to negatively impact innovation’

Hyderabad: Withdrawal of tax exemption for research and development is likely to negatively impact India’s innovation efforts, pharma major Dr Reddy’s Laboratories said on Wednesday.

Posted in NEWS, Policy | Tagged , , , | Leave a comment

Dr Reddy’s launches Nise D spray

Hyderabad: Strengthening its over the counter (OTC) portfolio, Pharma major Dr Reddy’s Laboratories on Monday announced the launch of Nise D spray, which offers quick and targeted pain killing.

Posted in NEWS, Pharmaceuticals | Tagged , , , | Leave a comment

Dr Reddy’s Laboratories posts Rs 647 crore net profit

Chennai: Pharmaceutical major Dr Reddy’s Laboratories Ltd said on Thursday it closed the second quarter with a net profit of Rs 647.52 crore as against Rs 433.59 crore in the same period last year.

Posted in NEWS, Pharmaceuticals | Tagged , | Leave a comment

Dr Reddy’s buys IP rights for anti-coagulant drug

Hyderabad: Dr Reddy’s Laboratories and Australian drug discovery and development company Alchemia have entered into a $17.5 million agreement giving the former worldwide exclusive intellectual property rights for anti-coagulant drug, a statement said on Friday.

Posted in NEWS, Pharmaceuticals | Tagged , , , , , | Leave a comment

Dr Reddy’s signs multimillion dollar deal with Hatchtech

Hyderabad: Pharma major Dr Reddy’s Laboratories on Monday announced the signing of a multi-million dollar commercialisation deal with Hatchtech, an Australian pharmaceutical company developing an anti-headlice Xeglyze lotion.

Posted in NEWS, Pharmaceuticals | Tagged , , , | Leave a comment